Withers tech team has advised biotech research firm Kynos Therapeutics on the deal.Kynos Therapeutics’ £9 million financing consisted of £6.5 million led by Epidarex Capital together with IP…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
